《口腔颌面外科杂志》 ›› 2025, Vol. 35 ›› Issue (1): 28-33. doi: 10.12439/kqhm.1005-4979.2025.01.005

• 基础研究 • 上一篇    下一篇

紫杉醇联合ipatasertib对口腔鳞状细胞癌细胞死亡、增殖及自噬的影响

车迪(), 徐鹏锟, 宋振宇, 任宝瑞, 关键()   

  1. 佳木斯大学附属口腔医院颌面外科,佳木斯  154002
  • 收稿日期:2023-03-24 接受日期:2023-11-02 出版日期:2025-02-28 上线日期:2025-02-28
  • 通讯作者: 关键
  • 作者简介:

    车迪,住院医师.E-mail:

The combination of paclitaxel and ipatasertib affects the death, proliferation, and autophagy response of oral squamous cell carcinoma cells

CHE Di(), XU Pengkun, SONG Zhenyu, REN Baorui, GUAN Jian()   

  1. Department of Maxillofacial Surgery, Jiamusi University Affiliated Stomatological Hospital, Jiamusi 154002, China
  • Received:2023-03-24 Accepted:2023-11-02 Published:2025-02-28 Online:2025-02-28
  • Contact: GUAN Jian

摘要:

目的: 探究紫杉醇联合ipatasertib对口腔鳞状细胞癌(oral squamous cell carcinoma,OSCC)细胞Cal-27致死率、增殖水平及自噬水平的影响,为OSCC的临床治疗提供理论基础。方法: 通过CCK8实验测定紫杉醇、ipatasertib在Cal-27细胞中单独用药及联合用药的吸光度,并比较相应的细胞致死率,获得最适宜的联合用药浓度;利用EDU实验观察紫杉醇、ipatasertib在单独用药及联合用药下的细胞增殖情况;通过细胞免疫荧光法比较不同组别间自噬相关蛋白LC3的表达情况;通过蛋白质印迹法检测自噬相关蛋白(mTOR、LC3、Beclin-1、P62)在不同组别中的表达情况。结果:紫杉醇、ipatasertib单独使用和联合用药均能够促进Cal-27细胞的死亡和增殖,且联合用药造成的细胞致死率和抑制效果高于单独用药;紫杉醇、ipatasertib单独使用及联合用药均增强了Cal-27细胞自噬,但联合用药作用效果强于单独用药。结论:紫杉醇、ipatasertib联合使用对OSCC细胞株Cal-27的死亡起到促进作用,对其增殖起到抑制作用,并且较单一用药效果增强,此外2种方式均不同程度地促进了自噬的发生。

关键词: 口腔鳞状细胞癌, 紫杉醇, ipatasertib, Cal-27细胞, 自噬

Abstract:

Objective: To investigate the effect of paclitaxel combined with ipatasrtib on the oral squamous cell carcinoma (OSCC) cell line Cal-27 to study the changes of the proliferation level and autophagy level, which will provide the basis for further research and clinical application of oral squamous cell carcinoma (OSCC).Methods: The optical density values ​​of paclitaxel and ipatasertib alone and in combination in Cal-27 cell line were determined by CCK8 assay, and the lethality of the corresponding drugs was further compared to find the most suitable concentration of combination therapy. The expression of autophagy-related protein LC3 among different groups was compared by cell immunofluorescence assay; the autophagy-related protein (mTOR, LC3, Beclin-1, P62) of different groups was observed by Western blotting.Results: Both paclitaxel and ipatasertib alone and in combination promoted the death and proliferation of Cal-27 cells, and the combination resulted in higher cell lethality and inhibition than alone; both paclitaxel and ipatasertib alone and in combination enhanced autophagy in Cal-27 cells, and the combination was more effective than alone.Conclusion: Paclitaxel combined with ipatasertib can promote the death of OSCC cell line Cal-27 and inhibit its proliferation, and the effect was enhanced compared with that of a single drug, and both methods promoted the occurrence of autophagy to varying degrees.

Key words: oral squamous cell carcinoma, paclitaxel, ipatasertib, Cal-27 cells, autophagy

中图分类号: